AMG 162 (Denosumab) Phase 3 Study (DESIRABLE Study) in Participants With Rheumatoid Arthritis on Disease-modifying Antirheumatic Drugs (DMARDs) Treatment

Clinical trial NCT01973569 · COMPLETED

Trial details

NCT number: NCT01973569
Sponsor: Daiichi Sankyo
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2013-10-01
Primary completion: 2015-12-01
Enrollment: 679

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.